PTGX Protagonist Therapeutics Inc
14.33 -0.13 (-0.90%)
Delayed Prices By NASDAQ, in USD Market Closed
PTGX Protagonist Therapeutics Inc
Market Cap
705.01M
Day’s Range
52W Range
Volume (3M)
905.64K
Price-Earnings Ratio
-
Revenue
35.2M
About Protagonist Therapeutics Inc
Protagonist Therapeutics is a healthcare company based in Newark, California, US and established in 1996. Operating locally, the company aims to meet as-yet-unmet medical requirements through the use of peptide drugs. It is traded on the NASDAQ GM under the stock ticker PTGX. PTGX stock is available on eToro. Learn more now!
Show More118
Employees
Newark, California, US
HQ
2006
Founded
Dinesh V. Patel, PhD
CEO
Upcoming Earnings
27
FEB
REPORTS
Protagonist Therapeutics Inc Q4 2022 earnings report is expected to be released after market open
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
53
Medium
Industry
Avg. 45
32
Environment
46
Social
68
Governance
People Also Bought
- SGMO Sangamo Therapeutics Inc -4.10%
- ALDX Aldeyra Therapeutics Inc -0.32%
- ATRA Atara Biotherapeutics Inc -5.31%
TSVT 2Seventy Bio Inc. 1.00%
- IOVA Iovance Biotherapeutics Inc. -1.85%